XELLARBIO

Xellar Biosystems is a Wet Artificial Intelligence (AI) biotechnology company, combining machine learning and AI with large-scale wet-lab experiments, tackling the most challenging problem in modern drug discovery - harnessing the complexity of human biology to accelerate drug discovery and development... Our platform combines our unique Organ-on-a-Chip technology, multicellular 3D disease model development, and Artificial Intelligence (AI) to provide spatiotemporal profiling and analysis of drug testing and treatment at a cellular level... Our microfluidic-based Organ-on-a-Chip technology recapitulates the multicellular microenvironment of the organ, incorporating vascularization, biomechanical structure and forces, and paracrine signaling experienced in vivo, providing an excellent in vitro model suitable for drug discovery.

Primary location: Boston United States